08:25 AM EDT, 07/07/2025 (MT Newswires) -- Organon (OGN) said Monday its Vtama cream was granted a "strong" recommendation by the American Academy of Dermatology in their 2025 updated guideline for the management of adults with atopic dermatitis, a condition that causes dry, itchy and inflamed skin.

The 2025 update includes therapies that have been recently approved by the US Food and Drug Administration into the American Academy of Dermatology's existing guidance on atopic dermatitis management.